Mesenchymal stromal cells support significant engraftment of low-risk myelodysplastic syndromes (MDS) in a murine xenograft model

被引：0

作者：

Medyouf, H. ^{[1
]}

Mossner, M. ^{[2
]}

Nolte, F. ^{[2
]}

Jann, J. C. ^{[2
]}

Nowak, V. ^{[2
]}

Zens, B. ^{[1
]}

Muedder, K. ^{[1
]}

Oblaender, J. ^{[2
]}

Fey, S. ^{[2
]}

Fabarius, A. ^{[2
]}

Riedl, E. ^{[3
]}

Marx, A. ^{[3
]}

Roehl, H. ^{[4
]}

Mueller, N. ^{[2
]}

Metzgeroth, G. ^{[2
]}

Huetter, G. ^{[5
]}

Hofmann, W. K. ^{[2
]}

Trumpp, A. ^{[6
]}

Nowak, D. ^{[2
]}

机构：

[1] German Canc Res Ctr, Dept Stem Cells & Canc, Heidelberg, Germany

[2] Heidelberg Univ, Med Fac Mannheim, Dept Hematol & Oncol, Mannheim, Germany

[3] Heidelberg Univ, Med Fac Mannheim, Dept Pathol, Mannheim, Germany

[4] Heidelberg Univ, Med Fac Mannheim, Dept Orthoped, Mannheim, Germany

[5] Heidelberg Univ, Med Fac Mannheim, Dept Transfus Med, Mannheim, Germany

[6] German Canc Res Ctr, Dept Stem Cells & Canc HiStem GmbH, Heidelberg, Germany

来源：

LEUKEMIA RESEARCH | 2013年 / 37卷

关键词：

D O I：

10.1016/S0145-2126(13)70035-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O-013

引用

页码：S14 / S14

页数：1

共 49 条

[1] Significant Engraftment of Immature Hematopoietic Cells From Patients with Low Risk Myelodysplastic Syndromes (MDS) in Immunodeficient Mice
Medyouf, Hind
Nolte, Florian
Mossner, Maximilian
Nowak, Verena
Zens, Bettina
Muedder, Katja
Oblaender, Julia
Fey, Stephanie
Klaumuenzer, Marion
Fabarius, Alice
Riedl, Eva
Marx, Alexander
Roehl, Henning
Mueller, Nadine
Metzgeroth, Georgia
Huetter, Gero
Hofmann, Wolf-Karsten
Trumpp, Andreas
Nowak, Daniel
BLOOD, 2012, 120 (21)
[2] An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes
Teodorescu, Patric
Pasca, Sergiu
Choi, Inyoung
Shams, Cynthia
Dalton, W. Brian
Gondek, Lukasz P.
DeZern, Amy E.
Ghiaur, Gabriel
HAEMATOLOGICA, 2024, 109 (01) : 337 - 342
[3] Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS)
Fenaux, P
SEMINARS IN ONCOLOGY, 2005, 32 (04) : S11 - S15
[4] Eltrombopag restores proliferative capacity and adipose-osteogenic balance of mesenchymal stromal cells in low-risk myelodysplastic syndromes
Hong, Minghua
Guo, Juan
Zhao, Youshan
Song, Luxi
Zhao, Sida
Wang, Roujia
Shi, Lei
Zhang, Zheng
Wu, Dong
He, Qi
Chang, Chunkang
EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 985
[5] HEPCIDIN AND ERYTHROFERRONE (ERFE) ARE NOT CORRELATED IN THE ANEMIA OF LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS)
Redondo, S.
Oarbeascoa, G.
Moran Jimenez, M. J.
Domingo, A.
Munoz Linares, C.
Moreno Carralero, M. I.
Bellon, J. M.
Del Campo Rincon, J. F.
Diez-Martin, J. L.
Font, P.
HAEMATOLOGICA, 2018, 103 : 183 - 184
[6] MESENCHYMAL STROMAL CELLS MAY ENHANCE RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS
Jimenez Solas, T.
Muntion Olave, S.
Lopez, F.
Ortega Herrera, R.
Martin Izquierdo, M.
Gonzalez Martinez, T.
Janusz, K.
Ezponda, T.
Vilas, A.
Alfonso, A.
Prosper, F.
Molero, A.
Valcarcel, D.
Sanchez-Guijo, F.
Diez-Campelo, M.
LEUKEMIA RESEARCH, 2021, 108 : S39 - S39
[7] IN VITRO STUDY OF BIOLOGICAL CHARACTERISTICS AND FUNCTIONS OF MESENCHYMAL STEM CELLS IN LOW-RISK MYELODYSPLASTIC SYNDROMES
Zhang, Y. Z.
Zhao, D. D.
Han, X. P.
Da, W. M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 376 - 377
[8] Mesenchymal stromal cells promote tumor engraftment and progression in tumor xenograft model
Park, Gyeongsin
Song, Byunghoo
Lee, Seonghak
Jung, Chan Kwon Jung
Lee, Ahwon
Chung, Yang-Guk
Choi, Yeong-Jin
Lee, Kyo-Young
Kang, Chang Suk
CANCER RESEARCH, 2013, 73 (08)
[9] Pathogenesis of iron overload in myelodysplastic syndromes and the debate on iron chelation in low-risk MDS
Shenoy, Niraj
Verma, Amit
Ginzburg, Yelena
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S85 - S85
[10] The Different Immunoregulatory Functions of Mesenchymal Stem Cells in Patients with Low-Risk or High-Risk Myelodysplastic Syndromes
Zhao, Zhigang
Wang, Zhenling
Li, Qiubai
Li, Weiming
You, Yong
Zou, Ping
PLOS ONE, 2012, 7 (09):

← 1 2 3 4 5 →